ZipRecruiter

Log In

1

Mlt Program Jobs in Beaverton, OR (NOW HIRING)

Lipovectra Inc.

Be Seen First

Principal Scientist - Toxicology & Translational Lead *Remote*

Portland, OR · Remote

$175K - $225K/yr

The role spans the full arc from early exploratory non-GLP research to IND-enabling packages -- owning the overall nonclinical development strategy for MLT-001 and future mRNA-LNP programs, including ...

Lipovectra Inc.

Be Seen First

Principal Scientist - Toxicology & Translational Lead *Remote*

Portland, OR · Remote

$175K - $225K/yr

The role spans the full arc from early exploratory non-GLP research to IND-enabling packages -- owning the overall nonclinical development strategy for MLT-001 and future mRNA-LNP programs, including ...

previous page

Showing results 21-35

All JobsMlt Program JobsMlt Program Jobs in Beaverton, OR

Mlt Program information

See Beaverton, OR salary details

$30.2K

$41.3K

$58.3K

How much do mlt program jobs pay per year?

As of Aug 23, 2026, the average yearly pay for mlt program in Beaverton, OR is $41,288.00, according to ZipRecruiter salary data. Most workers in this role earn between $35,400.00 and $40,600.00 per year, depending on experience, location, and employer.

What is an MLT program?

MLT programs, or Medical Laboratory Technician programs, are specialized educational courses designed to train individuals to perform laboratory tests and procedures that help doctors diagnose, treat, and prevent diseases. These programs typically combine classroom instruction with hands-on clinical training in laboratory settings. Graduates of MLT programs are prepared to work in hospitals, clinics, research labs, and other healthcare facilities. Most programs result in an associate degree or certificate, and graduates may be eligible for certification by professional organizations such as the American Society for Clinical Pathology (ASCP).

What are the key skills and qualifications needed to thrive as a Medical Laboratory Technician (MLT), and why are they important?

To thrive as a Medical Laboratory Technician (MLT), you need a solid background in laboratory science, attention to detail, and typically an associate degree in clinical laboratory science along with national certification. Familiarity with laboratory information systems (LIS), automated analyzers, and quality control protocols is essential. Strong problem-solving skills, teamwork, and effective communication help MLTs excel in fast-paced, accuracy-driven environments. These competencies ensure reliable test results, support patient care, and maintain high laboratory standards.

What does a typical week look like for a Medical Laboratory Technician (MLT) in a clinical lab?

As a Medical Laboratory Technician (MLT), your week typically involves performing a variety of diagnostic tests on patient samples, maintaining and calibrating laboratory equipment, and ensuring accurate documentation of results. You'll collaborate closely with other lab professionals, nurses, and physicians to deliver timely test results that support patient care. The workflow often includes rotating shifts, handling urgent cases, and adhering to strict safety and quality protocols. While the pace can be demanding, the role offers valuable hands-on experience and exposure to advanced laboratory technology, making it a strong foundation for career growth in clinical laboratory science.

What is the difference between Mlt Program vs Medical Laboratory Technician?

AspectMlt ProgramMedical Laboratory Technician
CredentialsCertificate or diploma from an accredited Mlt ProgramCertification often required, such as ASCP or AMT
Work EnvironmentEducational setting, training labs, or entry-level labsClinical laboratories, hospitals, diagnostic labs
Industry UsagePrepares students for certification and employmentPerforms lab tests, reports results

The Mlt Program is an educational pathway that prepares students to become certified Medical Laboratory Technicians. Once completed, graduates typically seek certification and employment as Medical Laboratory Technicians, who perform diagnostic tests in clinical labs. The program focuses on training, while the technician role involves hands-on testing and reporting. Both are essential in healthcare, with the program serving as the foundation for the technician career.

What are popular job titles related to Mlt Program jobs in Beaverton, OR?

For Mlt Program jobs in Beaverton, OR, the most frequently searched job titles are:

What job categories do people searching Mlt Program jobs in Beaverton, OR look for?

The top searched job categories for Mlt Program jobs in Beaverton, OR are:

What cities near Beaverton, OR are hiring for Mlt Program jobs?

Cities near Beaverton, OR with the most Mlt Program job openings:

Mlt Program jobs near you

Principal Scientist - Toxicology & Translational Lead (Fully Remote)

Lipovectra Inc

Portland, OR • Remote

$175K - $225K/yr

Full-time

Posted 2 days ago

New

Job description

About Lipovectra

Lipovectra Inc. is a preclinical biopharma company developing a pipeline of mRNA-LNP (lipid nanoparticle) therapeutics for in vivo adipose tissue engineering. Its lead asset is slated for first-in-human studies for Q3 2027. The company successfully completed the first tranche of its Series A raise.
Position Summary

We are seeking an experienced, versatile, and detail-oriented Principal Scientist to lead nonclinical strategy across the entire lifecycle of Lipovectra’s proprietary mRNA-LNP therapeutic platform. The role spans the full arc from early exploratory non-GLP research to IND-enabling packages — owning the overall nonclinical development strategy for MLT-001 and future mRNA-LNP programs, including species selection, dose selection, study sequencing, safety margins, toxicology endpoints, recovery design, TK/PK integration and regulatory positioning.
The incumbent will serve as a strategic partner to Discovery and Formulation teams and the official GLP Sponsor Study Monitor. A key focus of this position includes evaluating mRNA-LNP asset efficacy, safety and tolerability in specialized rodent models—specifically Diet-Induced Obesity (DIO) and custom/genetically engineered mouse models (GEMMs) for metabolic and target-driven pipeline expansion—while seamlessly advancing lead programs into definitive GLP repeat-dose studies in minipigs.
 
Key Responsibilities

1.     Exploratory Non-GLP Toxicology & Pipeline Expansion
a.     Early Candidate Screening: Design and manage non-GLP exploratory efficacy, safety, dose-range finding (DRF), pilot tolerability, and dose-escalation studies (in vitro and in vivo) to support early platform decision-making.
b.     Specialized Mouse Model Strategy: Oversee non-GLP efficacy and safety assessments in complex, disease-relevant rodent models, leveraging DIO mice and custom/transgenic/GEMMs to assess target-mediated liabilities, tissue delivery, lipid accumulation, and metabolic profile interactions.
c.     Indication & Platform Expansion: Partner closely with Discovery Biology, Chemistry, and Formulation Science to evaluate nonclinical efficacy and safety profiles for new therapeutic indications, organ-targeted delivery systems, and novel formulations. Drive alignment with internal platform scientists and external Contract Research Organizations (CRO) contacts on test article specifications, biospecimen collection and processing, biospecimen shipping & logistics, and analytical study design.
d.     Mechanistic Toxicity: Investigate platform-specific liabilities (e.g., innate immune/cytokine response, off-target organ accumulation, complement activation [CARPA], metabolic perturbance, and repeated-dosing tolerability) to establish early safety margins.
e.     Route & Delivery Exploration: Evaluate nonclinical delivery profiles with a primary focus on localized administration, target adipose tissue exposure, systemic exposure, and tissue biodistribution; experience exploring alternative routes (e.g., IV, IM, intratracheal, intrathecal) across exploratory animal models to broaden platform utility is desirable.
2.      GLP Study Oversight, CRO Operations, & Regulatory Monitoring

a.     Sponsor Study Monitor: Serve as the primary technical and regulatory contact overseeing outsourced GLP repeat-dose toxicology, safety pharmacology, developmental/reproductive toxicity (DART), and genotoxicity studies at CROs. Own end-to-end execution of external in vivo and ex vivo study packages, including study tracking infrastructure, test article logistics, biospecimen logistics, and timeline governance across CRO partners. Travel to CRO partners for in-person oversight of critical portions of studies.
b.     Minipig Platform Expertise: Lead the strategic selection, dosing protocol development, toxicokinetic (TK) assessment, and histopathology review for GLP studies in minipig models (Gottingen, Yucatan, or Hanford).
c.     CRO Management & On-Site Audit: Direct study initiation, protocol writing, live-phase monitoring, necropsy inspections, and final report sign-offs while ensuring strict adherence to FDA 21 CFR Part 58 and OECD GLP guidelines.
d.     Sample Integrity & Chain-of-Custody Governance: Establish and own end-to-end sample lifecycle management and chain-of-custody standards for biological matrices (primary tissues, animal organs, plasma, and cell lysates), including cataloging systems, storage conditions, and domestic/international shipping logistics spanning clinical donor sites, external CROs, and internal laboratories.
e.     Data Standards & Protocol Governance: Author, update, and review experimental protocols to embed FDA-compliant data requirements (e.g., CDISC SEND, 21 CFR Part 11) across nonclinical GLP toxicity and IND-enabling studies, setting the standard for regulatory-ready data capture from study initiation.
3.     Cross-Functional Leadership & Regulatory Submissions

a.     Nonclinical Safety Lead: Serve on cross-functional pipeline teams, integrating safety data with pharmacology, pharmacokinetics (PK), and clinical development strategy.
b.     Regulatory Authoring & Engagement: Author and review nonclinical safety summaries for global regulatory submissions, including IND, CTA, IMPD, and Investigator's Brochure (specifically eCTD Module 4). Engage with regulatory authorities (FDA, EMA, etc.) during pre-IND meetings and respond to agency queries regarding nonclinical safety packages.

Required Qualifications

  • Education: Ph.D. in Toxicology, Pharmacology, Pathology, Veterinary Medicine (D.V.M.), or a related life sciences field OR M.S. in Toxicology/Pharmacology with 7+ years of pharmaceutical/biotech industry experience spanning discovery through GLP toxicology.
  • 7–10+ years of pharmaceutical/biotech industry experience in nonclinical safety assessment.
  • Proven track record across both non-GLP exploratory/discovery toxicology (pipeline de-risking) and GLP regulatory toxicology.
  • In-depth scientific knowledge of mRNA therapeutics, LNP formulations, and platform-associated toxicities.
  • Experience with interpreting biodistribution / tissue exposure data for nucleic-acid therapeutics and/or LNPs.
  • Hands-on experience working with minipig or non-rodent large animal models, including tailored dosing, clinical pathology, and tissue collection protocols, with deep command of standard in vivo study execution — dosing routes, sampling schedules, necropsy procedures — and downstream biological sample processing workflows.
  • Extensive experience serving as a Sponsor Study Monitor managing CROs, protocol amendments, and GLP compliance audits, including acting as the primary operational and scientific point of contact for CROs, central labs, and clinical collection partners.
  • Demonstrated experience establishing and overseeing biological specimen inventory and chain-of-custody systems, including LIMS implementation and cold-chain shipping protocols across multi-site study networks.
  • Mastery of global nonclinical guidelines (FDA 21 CFR Part 58, OECD GLP, ICH M3(R2), ICH S6, ICH S9).
 
Preferred Qualifications

  • DABT (Diplomate of the American Board of Toxicology) certification
  • Prior experience managing test articles or biological samples derived from nucleic acid therapeutics, LNPs, or novel delivery platforms.
  • Hands-on or oversight experience using DIO rodent models and custom/transgenic/ GEMMs to evaluate safety, target-mediated effects, and metabolic parameters.
  • Experience with 3D culture systems, including patient-derived organoids.
  • Experience in oncology. 

Professional Competencies

  • Analytical Problem-Solving: Strong analytical and critical-thinking skills to investigate mechanistic liabilities, troubleshoot complex study issues, and resolve technical challenges.
  • Communication: Advanced technical writing and presentation skills, with the ability to convey complex scientific data clearly to regulatory authorities, cross-functional teams, and corporate stakeholders.
  • Autonomy & Agility: Proven ability to self-direct and manage multiple concurrent programs in a fast-paced, matrixed startup environment without relying on layered support staff. 

Compensation

Salary: $175,000 – $225,000
*Final compensation depends on candidate location, level of experience, and DABT board certification.


Equal Opportunity Employer

Lipovectra Inc. is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. All employment decisions are based on business needs, job requirements, and individual qualifications, without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran status, disability, age, or any other status protected by applicable laws and regulations.